Cutler Group LP Gsk PLC Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$42.05 - $47.77 $188,804 - $214,487	-4,490 Reduced 43.38%	5,860 $255,000
Q4 2021 Jan 18, 2022	SELL	$38.88 - $45.31 $311,156 - $362,615	-8,003 Reduced 43.61%	10,350 $456,000
Q3 2021 Oct 26, 2021	BUY	$38.79 - $43.16 $673,006 - $748,825	17,350 Added 1729.81%	18,353 $701,000
Q2 2021 Jul 19, 2021	BUY	$36.52 - $41.46 $36,629 - $41,584	1,003 New	1,003 $39,000
Q2 2019 Aug 09, 2019	SELL	$39.4 - $42.7 $5,200 - $5,636	-132 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$38.57 - $42.69 $5,091 - $5,635	132 New	132 $5,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.